• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孟加拉国增加腹膜透析使用的障碍:患者与医护人员调查

Barriers to Increasing Use of Peritoneal Dialysis in Bangladesh: A Survey of Patients and Providers.

作者信息

Savla Dipal, Ahmed Sweety, Yeates Karen, Matthew Anna, Anand Shuchi

机构信息

Icahn School of Medicine at Mt. Sinai, New York, NY, USA

Dhaka Medical College Hospital, Dhaka, Bangladesh.

出版信息

Perit Dial Int. 2017 Mar-Apr;37(2):234-237. doi: 10.3747/pdi.2016.00177.

DOI:10.3747/pdi.2016.00177
PMID:28360370
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5545084/
Abstract

Despite a lower requirement for technology and equipment than hemodialysis (HD), peritoneal dialysis (PD) is an underutilized modality in low- and middle-income countries (LMICs). Bangladesh has lowest use of PD in the world (fewer than 2% of prevalent patients). We evaluated nephrologists' attitudes toward PD and examined differences between patients on HD and PD in Dhaka. We asked nephrologists to fill out an English-language questionnaire. Using convenience sampling but targeting both public and private hospitals in Dhaka, we asked trained nurses to administer a Bangla-language questionnaire to patients on HD ( = 116) and PD ( = 41). We validated the questionnaires on a sub-sample ( = 10 for each group). Of the 43 nephrologists surveyed, 27 (63%) had patients on PD. When compared with nephrologists without patients on PD, those with patients on PD were less likely to believe that survival and quality of life on PD was worse than on HD (odds ratio [OR] = 0.21, 95% confidence interval [CI] 0.05 - 0.83 and OR = 0.11, 95% CI 0.02 - 0.67 respectively) but were more likely to have received training for PD. Nephrologists named cost of PD as the predominant barrier to increasing use of PD, followed by concerns about patient hygiene and lack of trained nurses. Fifty-two HD patients (45%) did not know about a home-based modality. When compared with patients on HD, patients on PD were more likely to have been educated by non-nephrologists about dialysis, to be "forewarned" about the need for dialysis, to be paying fully, and to be living in a permanent home with a non-communal water source. Some barriers to increasing access to PD-i.e., patient living conditions and cost-are unique to LMICs. Our study also highlights that issues encountered in high-income countries-i.e., nephrologists' subjective preference and lack of patient knowledge about an alternate modality to HD-may play a role as well.

摘要

尽管腹膜透析(PD)对技术和设备的要求低于血液透析(HD),但在低收入和中等收入国家(LMICs),它却是一种未得到充分利用的治疗方式。孟加拉国是全球腹膜透析使用率最低的国家(患病率不到2%)。我们评估了肾病学家对腹膜透析的态度,并研究了达卡接受血液透析和腹膜透析的患者之间的差异。我们让肾病学家填写一份英文问卷。采用便利抽样法,但针对达卡的公立医院和私立医院,我们让经过培训的护士向接受血液透析(n = 116)和腹膜透析(n = 41)的患者发放一份孟加拉语问卷。我们在一个子样本(每组n = 10)上对问卷进行了验证。在接受调查的43名肾病学家中,有27名(63%)的患者接受腹膜透析治疗。与没有腹膜透析患者的肾病学家相比,有腹膜透析患者的肾病学家不太可能认为腹膜透析患者的生存率和生活质量比血液透析患者差(优势比[OR]分别为0.21,95%置信区间[CI] 0.05 - 0.83和OR = 0.11,95% CI 0.02 - 0.67),但更有可能接受过腹膜透析培训。肾病学家指出腹膜透析的费用是增加其使用的主要障碍,其次是对患者卫生状况的担忧和缺乏训练有素的护士。52名血液透析患者(45%)不知道有居家治疗方式。与接受血液透析的患者相比,接受腹膜透析的患者更有可能由非肾病学家进行透析教育,更有可能提前得知透析需求,全额付费,并且居住在有非公共水源的固定住所。增加腹膜透析可及性的一些障碍,如患者生活条件和费用,是低收入和中等收入国家所特有的。我们的研究还强调,高收入国家遇到的问题,如肾病学家的主观偏好和患者对血液透析替代方式缺乏了解,可能也起到了一定作用。

相似文献

1
Barriers to Increasing Use of Peritoneal Dialysis in Bangladesh: A Survey of Patients and Providers.孟加拉国增加腹膜透析使用的障碍:患者与医护人员调查
Perit Dial Int. 2017 Mar-Apr;37(2):234-237. doi: 10.3747/pdi.2016.00177.
2
Factors affecting the use of peritoneal dialysis among the ESRD population in India: a single-center study.影响印度终末期肾病患者腹膜透析使用情况的因素:一项单中心研究。
Perit Dial Int. 2004 Nov-Dec;24(6):538-41.
3
Attitudes of Canadian nephrologists toward dialysis modality selection.加拿大肾病学家对透析方式选择的态度。
Perit Dial Int. 1999 May-Jun;19(3):263-8.
4
Are North American nephrologists biased against peritoneal dialysis?北美肾脏病学家对腹膜透析有偏见吗?
Perit Dial Int. 2001 Jul-Aug;21(4):335-7.
5
What do American nephologists think about dialysis modality selection?美国肾脏病专家对透析方式的选择有何看法?
Am J Kidney Dis. 2001 Jan;37(1):22-29. doi: 10.1053/ajkd.2001.20635.
6
Choosing peritoneal dialysis reduces the risk of invasive access interventions.选择腹膜透析可降低有创通路干预的风险。
Nephrol Dial Transplant. 2012 Feb;27(2):810-6. doi: 10.1093/ndt/gfr289. Epub 2011 Jun 21.
7
Factors influencing dialysis modality for end-stage renal disease in developing countries: a survey of Filipino nephrologists.影响发展中国家终末期肾病透析方式的因素:对菲律宾肾病学家的调查。
Blood Purif. 2011;32(2):117-23. doi: 10.1159/000324396. Epub 2011 Apr 29.
8
Introduction of Renal Key Performance Indicators Associated with Increased Uptake of Peritoneal Dialysis in a Publicly Funded Health Service.在公共资助的医疗服务中,与腹膜透析使用率增加相关的肾脏关键绩效指标介绍。
Perit Dial Int. 2017 Mar-Apr;37(2):198-204. doi: 10.3747/pdi.2016.00149. Epub 2016 Sep 28.
9
Peritoneal Dialysis Use and Practice Patterns: An International Survey Study.腹膜透析的使用和实践模式:一项国际调查研究。
Am J Kidney Dis. 2021 Mar;77(3):315-325. doi: 10.1053/j.ajkd.2020.05.032. Epub 2020 Aug 12.
10
Attitudes of British Isles nephrologists towards dialysis modality selection: a questionnaire study.不列颠群岛肾病学家对透析方式选择的态度:一项问卷调查研究。
Nephrol Dial Transplant. 2002 Mar;17(3):474-7. doi: 10.1093/ndt/17.3.474.

引用本文的文献

1
International equity in access to home dialysis.国际上在家庭透析方面的可及性公平性。
Curr Opin Nephrol Hypertens. 2025 Jan 1;34(1):112-120. doi: 10.1097/MNH.0000000000001027. Epub 2024 Sep 19.
2
Global Dialysis Perspective: Bangladesh.全球透析视角:孟加拉国
Kidney360. 2023 Oct 1;4(10):e1472-e1475. doi: 10.34067/KID.0000000000000232.
3
Pragmatic Recommendations for the Prevention and Treatment of Acute Kidney Injury in Patients with COVID-19 in Low- and Middle-Income Countries.中低收入国家 COVID-19 患者急性肾损伤预防和治疗的实用建议。

本文引用的文献

1
Nursing education in Bangladesh: a social business model.孟加拉国的护理教育:一种社会商业模式。
Int Nurs Rev. 2016 Jun;63(2):285-91. doi: 10.1111/inr.12243. Epub 2016 Feb 2.
2
Chronic kidney disease hotspots in developing countries in South Asia.南亚发展中国家的慢性肾脏病高发地区
Clin Kidney J. 2016 Feb;9(1):135-41. doi: 10.1093/ckj/sfv109. Epub 2015 Nov 17.
3
The gap between estimated incidence of end-stage renal disease and use of therapy.估算的终末期肾病发病率与治疗使用率之间的差距。
Am J Trop Med Hyg. 2021 Jan 11;104(3_Suppl):87-98. doi: 10.4269/ajtmh.20-1242.
4
Non-medical barriers reported by nephrologists when providing renal replacement therapy or comprehensive conservative management to end-stage kidney disease patients: a systematic review.肾内科医生在为终末期肾病患者提供肾脏替代治疗或全面保守治疗时报告的非医学障碍:系统评价。
Nephrol Dial Transplant. 2021 Apr 26;36(5):848-862. doi: 10.1093/ndt/gfz271.
PLoS One. 2013 Aug 30;8(8):e72860. doi: 10.1371/journal.pone.0072860. eCollection 2013.
4
Peritoneal dialysis-first policy made successful: perspectives and actions.腹膜透析优先策略取得成功:观点与行动。
Am J Kidney Dis. 2013 Nov;62(5):993-1005. doi: 10.1053/j.ajkd.2013.03.038. Epub 2013 Jun 7.
5
Cost of peritoneal dialysis and haemodialysis across the world.全球腹膜透析和血液透析的成本。
Nephrol Dial Transplant. 2013 Oct;28(10):2553-69. doi: 10.1093/ndt/gft214. Epub 2013 Jun 4.
6
Global trends in rates of peritoneal dialysis.全球腹膜透析率趋势。
J Am Soc Nephrol. 2012 Mar;23(3):533-44. doi: 10.1681/ASN.2011060607. Epub 2012 Feb 2.
7
Geographic and educational factors and risk of the first peritonitis episode in Brazilian Peritoneal Dialysis study (BRAZPD) patients.巴西腹膜透析研究(BRAZPD)患者首次腹膜炎发作的地理和教育因素及风险。
Clin J Am Soc Nephrol. 2011 Aug;6(8):1944-51. doi: 10.2215/CJN.11431210. Epub 2011 Jul 7.
8
How to make peritoneal dialysis affordable in developing countries.如何在发展中国家使腹膜透析变得可负担得起。
Contrib Nephrol. 2009;163:243-249. doi: 10.1159/000223805. Epub 2009 Jun 3.
9
Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 Peritonitis Study.腹膜透析中单一微生物腹膜炎的结局:第9网络腹膜炎研究中的革兰阴性菌与革兰阳性菌对比
Kidney Int. 1997 Aug;52(2):524-9. doi: 10.1038/ki.1997.363.